Nav
Journal
medRxiv
Publication year
2020
Suggested citation
Wagner A, Guzek A, Ruff J, Jasinska J, Scheikl U, Zwazl I, Kundi M, Stockinger H, Farcet MR, Kreil TR, Hoeltl E, Wiedermann U. A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint. medRxiv. 2020.